Chengdu Pharmaceutical

Chengdu Pharmaceutical Co., Ltd. is a long-standing pharmaceutical manufacturer based in Chengdu, China, and a subsidiary of the state-owned China Meheco Group. Originally established in 1951 as the Chengdu Pharmaceutical Factory, the company has a deep history in the production of chemical drugs, active pharmaceutical ingredients (APIs), and traditional Chinese medicines. Its product portfolio includes a wide range of generic medications such as antivirals, anti-hypertensives, and analgesics, serving both domestic and international markets. The company operates large-scale manufacturing facilities that comply with Chinese GMP standards and is actively involved in the modernization of traditional therapies. Following its acquisition by China Meheco in 2016, Chengdu Pharmaceutical has focused on modernizing its production lines and expanding its generic drug pipeline, including bioequivalence studies for modern therapies like vonoprazan.